CCDC76 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.701400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.501400E-01
Normal-vs-Stage2
3.727400E-01
Normal-vs-Stage3
2.427400E-01
Normal-vs-Stage4
4.962400E-01
Stage1-vs-Stage2
2.954400E-01
Stage1-vs-Stage3
1.154280E-02
Stage1-vs-Stage4
7.050000E-01
Stage2-vs-Stage3
2.598000E-04
Stage2-vs-Stage4
1.900840E-01
Stage3-vs-Stage4
8.217000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.720000E-01
Normal-vs-AfricanAmerican
4.206000E-01
Normal-vs-Asian
3.347400E-01
Caucasian-vs-AfricanAmerican
5.482400E-01
Caucasian-vs-Asian
3.524400E-01
AfricanAmerican-vs-Asian
3.525800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.640600E-01
Normal-vs-Female
3.798600E-01
Male-vs-Female
4.922400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.889800E-01
Normal-vs-Age(41-60Yrs)
3.984200E-01
Normal-vs-Age(61-80Yrs)
3.585400E-01
Normal-vs-Age(81-100Yrs)
3.604400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.677200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.562400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.687400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.222240E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.543800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.922200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.590000E-01
Normal-vs-Daily Drinker
3.512400E-01
Normal-vs-Weekly Drinker
3.163800E-01
Normal-vs-Occasional Drinker
4.115800E-01
Normal-vs-Social Drinker
3.772800E-01
Non Drinker-vs-Daily Drinker
8.334200E-01
Non Drinker-vs-Weekly Drinker
2.848000E-01
Non Drinker-vs-Occasional Drinker
2.551000E-01
Non Drinker-vs-Social Drinker
6.850400E-01
Daily Drinker-vs-Weekly Drinker
4.405800E-01
Daily Drinker-vs-Occasional Drinker
2.373200E-01
Daily Drinker-vs-Social Drinker
5.905200E-01
Weekly Drinker-vs-Occasional Drinker
5.364400E-02
Weekly Drinker-vs-Social Drinker
1.676640E-01
Occasional Drinker-vs-Social Drinker
5.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.268000E-01
Normal-vs-Grade 2
1.855390E-01
Normal-vs-Grade 3
2.253600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.865800E-01
Grade 1-vs-Grade 3
7.480400E-01
Grade 1-vs-Grade 4
4.268000E-01
Grade 2-vs-Grade 3
7.600200E-01
Grade 2-vs-Grade 4
1.855390E-01
Grade 3-vs-Grade 4
2.253600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.399800E-01
Normal-vs-NonDiabetic
3.599800E-01
Diabetic-vs-NonDiabetic
3.953200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.421800E-01
Normal-vs-NoPancreatitis
3.545000E-01
Pancreatitis-vs-NoPancreatitis
6.846400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.690400E-01
Normal-vs-N1
3.715800E-01
N0-vs-N1
8.964600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.726600E-01
Normal-vs-TP53-NonMutant
3.970600E-01
TP53-Mutant-vs-TP53-NonMutant
4.934200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
